Tom Swaan - Koninklijke DSM Member of the Supervisory Board
Executive
Mr. Tom de Swaan serves as Independent Deputy Chairman of the Supervisory Board at Royal DSM N.V. Prior to this, he was Member of the Supervisory Board at the Company. is Chairman of the Company Audit Committee and Member of Remuneration Committee of the Company. He is currently retired. The last position he held was Member of the Managing Board and Chief Financial OfficerChief Risk Officer ABN AMRO. Mr. de Swaan also served as NonExecutive Director of the Board of GlaxoSmithKline Plc. He is Chairman and Chief Executive Officer of Zurich Financial Services, member Supervisory Board of Van Lanschot Bankiers, chairman Board of Trustees of Netherlands Cancer InstituteAntoni van Leeuwenhoek Hospital and chairman Advisory Board Rotterdam School of Management since 2016.
| Age | 71 |
| Tenure | 8 years |
| Phone | 31 45 578 8111 |
| Web | https://www.dsm.com |
Koninklijke DSM Management Efficiency
The company has return on total asset (ROA) of 0.0402 % which means that it generated a profit of $0.0402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1189 %, meaning that it generated $0.1189 on every $100 dollars invested by stockholders. Koninklijke DSM's management efficiency ratios could be used to measure how well Koninklijke DSM manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 2.84 B in total debt with debt to equity ratio (D/E) of 0.31, which is about average as compared to similar companies. Koninklijke DSM NV has a current ratio of 2.46, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Koninklijke DSM until it has trouble settling it off, either with new capital or with free cash flow. So, Koninklijke DSM's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Koninklijke DSM NV sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Koninklijke to invest in growth at high rates of return. When we think about Koninklijke DSM's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Howard Cyr | Teleflex Incorporated | N/A | |
| Adam Portnoy | Office Properties Income | 47 | |
| Guy Shemesh | Radcom | 50 | |
| Tracy Fuerst | Magna International | N/A | |
| Elena Poptodorova | Office Properties Income | 66 | |
| Louis Tonelli | Magna International | N/A | |
| Moran Adania | Radcom | N/A | |
| Barbara Gilmore | Office Properties Income | 67 | |
| DeAnna Osteen | Weyco Group | N/A | |
| Michelle Fox | Teleflex Incorporated | N/A | |
| Michal Fridman | Radcom | N/A | |
| Brian Lloyd | Merit Medical Systems | 63 | |
| John Harrington | Office Properties Income | 81 | |
| Jeffrey Somers | Office Properties Income | 75 | |
| William Lamkin | Office Properties Income | 58 | |
| Harel Givon | Radcom | 44 | |
| Joanne Horibe | Magna International | N/A | |
| James Zaliwski | American Axle Manufacturing | 52 | |
| Jennifer Clark | Office Properties Income | 63 | |
| Sharon Lennon | Marine Products | N/A | |
| Sarah Comstock | Merit Medical Systems | N/A | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0402 |
Koninklijke DSM NV Leadership Team
Elected by the shareholders, the Koninklijke DSM's board of directors comprises two types of representatives: Koninklijke DSM inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Koninklijke. The board's role is to monitor Koninklijke DSM's management team and ensure that shareholders' interests are well served. Koninklijke DSM's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Koninklijke DSM's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Routs, Chairman of the Supervisory Board | ||
| Eileen Kennedy, Member of the Supervisory Board | ||
| Ewald Kist, Deputy Chairman of the Supervisory Board | ||
| Frits Paasschen, Independent Member of the Supervisory Board | ||
| John Ramsay, Independent Member of the Supervisory Board | ||
| Stefan Doboczky, Member of the Managing Board | ||
| Paul Gilgen, Head Products | ||
| Lieke JongTops, Communications Mang | ||
| Stephan Tanda, Member of the Managing Board | ||
| Geraldine Matchett, CFO and Member of the Managing Board | ||
| Luca Rosetto, VP Products | ||
| Dimitri Vreeze, Member of the Managing Board | ||
| Dave Huizing, Vice President Investor Relations | ||
| Rob Atsma, Head Nederland | ||
| Pauline Mohr, Member of the Supervisory Board | ||
| Victoria Haynes, Member of the Supervisory Board | ||
| Jan Wolters, Head Chemicals | ||
| Bruno Mller, Head Products | ||
| Pradeep Pant, Member of the Supervisory Board | ||
| Manfred Eggersdorfer, VP Advocacy | ||
| Feike Sijbesma, Chairman of the Managing Board and CEO | ||
| Pierre Hochuli, Member of the Supervisory Board | ||
| Tom Swaan, Member of the Supervisory Board |
Koninklijke Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Koninklijke DSM a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0402 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 24.43 B | |||
| Shares Outstanding | 691.88 M | |||
| Shares Owned By Institutions | 0.15 % | |||
| Price To Earning | 38.86 X | |||
| Price To Book | 2.36 X | |||
| Price To Sales | 2.39 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Koninklijke DSM in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Koninklijke DSM's short interest history, or implied volatility extrapolated from Koninklijke DSM options trading.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Koninklijke OTC Stock
If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |